Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts

Principal Investigator: Andrew Rosenblum

Despite the high prevalence of opioid addiction among persons under criminal justice supervision there has been very limited penetration of medication assisted treatment (MAT; methadone, buprenorphine, and extended-release naltrexone); an intervention that has a very strong evidence base. To spur implementation of MAT, we propose a Stage I study to develop and assess the feasibility, acceptability, utility and sustainability of an interactive eLearning modality and an eLearning + an organizational approach (Technology Transfer [TT] model) to advance knowledge and facilitate inclusion of MAT in drug and felony courts. We expect this development/pilot project to lead to a protocol that will be tested in a larger-scale efficacy trial to implement evidenced-based therapy for opioid-addicted criminal justice clients.

For more information: Abstract

  • About NDRI
          Since 1967, National Development and Research Institutes, Inc. (NDRI), a private, not-for-profit 501(c)(3) organization, has conducted substance use and other bio-behavioral research nationwide and throughout the world.

          Drawing on the expertise of our interdisciplinary professional staff and our partners such as medical centers, treatment and prevention programs, universities, CBOs, industry and government NDRI has advanced public health across diverse populations including high-risk and underserved persons, uniformed services, youth and veterans.

          In addition to its focus on addiction, NDRI, organized under specialized institutes, has generated scientific discoveries associated with infectious diseases (particularly HIV and Hepatitis C), overdose, chronic pain, prevention of cardiovascular disease and cancer, tobacco control and criminal justice.


    Follow Us on Facebook